Exporting Rehabilitation and Mobility Devices to the US — Home Health Distributors

Rehabilitation and mobility devices — including wheelchairs, walkers, rollators, crutches, canes, patient lifts, and transfer aids — form the backbone of home healthcare delivery in the United States. With over 12 million Americans using mobility assistive devices in 2022, according to the Centers for Disease Control and Prevention, demand continues to accelerate as the population ages and chronic conditions become more prevalent [1]. For US home health distributors, sourcing these devices from Latin America and Africa offers a compelling value proposition: competitive pricing, quality manufacturing aligned with FDA standards, and shorter supply chains relative to traditional Asian sourcing hubs.

Latin American manufacturers, particularly in Mexico, Brazil, and Colombia, have developed robust production capabilities for standard and custom mobility devices. These producers benefit from proximity to the US market, preferential trade agreements such as the USMCA, and labor costs that remain significantly lower than North American benchmarks. African suppliers, emerging in South Africa and Kenya, are gaining traction in niche segments like lightweight manual wheelchairs and pediatric mobility aids [2]. This page provides a comprehensive guide for US home health distributors evaluating supplier options in these regions.

Product Specifications and Grades Relevant to US Buyers

US home health distributors require rehabilitation and mobility devices that meet strict regulatory and performance standards. The primary governing body is the Food and Drug Administration (FDA), which classifies most mobility devices as Class I or Class II medical devices. Class I devices, such as canes and walkers, require general controls, while Class II devices, like powered wheelchairs and patient lifts, necessitate premarket notification (510(k)) clearance [3].

Key product categories and their specifications include:

Manual Wheelchairs: US buyers typically source K0001 (standard manual wheelchair) and K0005 (ultralightweight manual wheelchair) codes under the Medicare DME fee schedule. Standard models weigh 35–45 lbs and support up to 250 lbs, while bariatric variants handle 400+ lbs. Frame materials range from steel to aluminum to titanium, with folding and rigid frame designs. Compliance with ANSI/RESNA WC-1 standards for wheelchair safety and performance is mandatory [4].

Power Wheelchairs and Scooters: Group 2 power wheelchairs (mid-wheel drive, front-wheel drive) and Class 2 scooters require FDA 510(k) clearance and must meet ISO 7176 series standards for stability, braking, and electromagnetic compatibility. Battery types (sealed lead-acid vs. lithium-ion) and weight capacity are critical differentiators.

Walkers and Rollators: Standard walkers (E0130), wheeled walkers (E0143), and rollators with seats (E0144) must comply with ASTM F2012-18 for stability and strength. Height adjustability, foldability, and weight capacity (typically 250–350 lbs) are key specs.

Patient Lifts: Manual and powered lifts (HCPCS codes E0621, E0630) require FDA Class II clearance and must meet ISO 10535 standards for safety and load testing. Capacities range from 300 to 600 lbs, with sling compatibility.

Crutches and Canes: Axillary crutches (E0110), forearm crutches (E0111), and canes (E0100) are Class I devices. Materials include aluminum and carbon fiber, with adjustable height and ergonomic grips.

US home health distributors prioritize devices that are durable, lightweight, and easy to clean, as many are used in institutional settings or by patients with compromised immune systems. Product labeling must include manufacturer name, device identifier, and instructions for use in English, complying with 21 CFR Part 801 [3].

LATAM and Africa Supplier Landscape for Rehabilitation and Mobility Devices

Latin America has become a significant manufacturing hub for rehabilitation and mobility devices, driven by favorable trade policies, skilled labor, and growing domestic healthcare markets. Mexico leads the region as the top exporter of medical devices to the US, with over $12 billion in exports in 2022, a substantial portion of which includes mobility aids [5]. Key Mexican manufacturing clusters are located in Baja California, Nuevo León, and Jalisco, where companies like Invacare and Drive Medical have established production facilities. Mexican suppliers offer competitive pricing — typically 15–25% lower than US-manufactured equivalents — while maintaining FDA compliance through ISO 13485 certification.

Brazil is the second-largest LATAM exporter of medical devices, with a strong focus on manual wheelchairs and bariatric equipment. Brazilian manufacturers, such as Ortobras and Freedom, benefit from the country’s advanced industrial base and government incentives for assistive technology production. However, import duties under the US-Brazil trade framework (average 2–4% for medical devices) and longer lead times (6–10 weeks) may offset some cost advantages.

Colombia’s medical device sector has grown rapidly, with exports increasing 18% annually since 2019 [6]. Colombian suppliers specialize in lightweight wheelchairs and rollators, leveraging local aluminum and steel supply chains. The US-Colombia Trade Promotion Agreement eliminates tariffs on most medical devices, making Colombian products cost-competitive. Lead times from Colombian ports to Miami average 5–7 days.

In Africa, South Africa is the dominant producer, with companies like Wheelchairs of Hope and Rehab South Africa exporting manual wheelchairs to the US under preferential trade programs like AGOA, which provides duty-free access for qualifying products. South African manufacturers offer unique value in custom and pediatric mobility devices, often using locally sourced materials. However, logistical challenges — including longer transit times (15–25 days) and port congestion — require careful planning [7]. Kenya’s emerging sector focuses on low-cost, rugged wheelchairs designed for rough terrain, appealing to US buyers seeking durable, entry-level products.

Supplier due diligence is critical: US home health distributors should verify ISO 13485 certification, FDA establishment registration, and compliance with US import regulations. Audits, sample testing, and site visits are recommended before contracting.

US Buyer Types — Who Buys These Devices and How They Procure

The US market for rehabilitation and mobility devices is fragmented across several buyer segments, each with distinct procurement behaviors and requirements.

Home Health Distributors: These are primary buyers, serving home healthcare agencies, durable medical equipment (DME) suppliers, and individual patients. Distributors typically purchase in bulk (500–5,000 units per order) and require consistent quality, reliable lead times (4–8 weeks), and competitive pricing. They often maintain vendor-managed inventory agreements and demand drop-shipping capabilities. Key decision factors include warranty terms (1–3 years), return policies, and compliance with Medicare and private payer reimbursement codes.

Durable Medical Equipment Suppliers: DME suppliers focus on direct-to-patient delivery and often require custom branding, packaging, and patient instructions. They prioritize devices that meet specific HCPCS codes and are eligible for Medicare reimbursement. Many DME suppliers source through distributors but increasingly seek direct manufacturer relationships for better margins.

Home Healthcare Agencies: Agencies providing skilled nursing and therapy services purchase devices for patient use. They favor lightweight, easy-to-transport equipment and require training materials for staff. Procurement is often decentralized, with individual branches making purchasing decisions.

Group Purchasing Organizations (GPOs): GPOs aggregate demand across multiple agencies and negotiate volume discounts. They represent a high-volume, low-margin channel that requires strict adherence to quality standards and pricing transparency. GPO contracts typically span 1–3 years and include performance metrics.

Government and Institutional Buyers: Federal and state agencies, including the Department of Veterans Affairs (VA) and Medicaid programs, purchase through competitive bidding processes. These buyers demand the lowest prices and rigorous compliance with federal procurement regulations. The VA, for example, procures over 100,000 wheelchairs annually through its Prosthetics and Sensory Aids Service [1].

Procurement processes vary: distributors and DME suppliers often use RFQs and sample evaluations, while GPOs and government buyers conduct formal RFPs with pre-qualification requirements. US buyers increasingly demand digital catalogs, EDI integration, and real-time inventory visibility.

Certifications and Import Requirements for Rehabilitation and Mobility Devices

Exporting rehabilitation and mobility devices to the US requires navigating a complex regulatory landscape. The FDA is the primary authority, classifying devices based on risk. Most mobility aids are Class I (crutches, canes, walkers) or Class II (wheelchairs, patient lifts). Class II devices require a 510(k) premarket notification demonstrating substantial equivalence to a predicate device [3].

Key certifications and requirements include:

FDA Establishment Registration and Device Listing: Every foreign manufacturer must register with the FDA and list each device type. Registration is renewed annually, with a fee of $6,259 for FY2024 (small business exemptions available).

ISO 13485:2016: This quality management system certification is essential for demonstrating compliance with FDA requirements. Most US buyers require it as a condition of doing business.

ANSI/RESNA Standards: Wheelchairs must meet ANSI/RESNA WC-1 (formerly WC-2) for safety, durability, and performance. Testing includes static stability, impact resistance, and fatigue life.

ASTM and ISO Standards: Walkers and rollators must comply with ASTM F2012-18; patient lifts with ISO 10535; power wheelchairs with ISO 7176 series. These standards cover mechanical, electrical, and safety requirements.

Import Customs Clearance: Devices must be properly classified under HTSUS codes (e.g., 8713.10.00 for wheelchairs, 9021.10.00 for orthopedic appliances). Importers must provide FDA Prior Notice for each shipment, submitted via the Automated Commercial Environment (ACE) system. Customs may require certificates of origin for preferential duty treatment under USMCA or AGOA [8].

Labeling Requirements: Devices must be labeled with manufacturer name and address, device identifier (e.g., model number), quantity, and instructions for use in English. Medical device labeling must comply with 21 CFR Part 801, including unique device identifier (UDI) requirements for most Class II devices.

Post-Market Surveillance: Manufacturers must report adverse events to the FDA via the Medical Device Reporting (MDR) system and maintain complaint files. Failure to comply can result in import alerts or product seizures.

Pricing and Lead Time Context

Pricing for rehabilitation and mobility devices varies widely based on product type, materials, and certification complexity. General ranges for LATAM-sourced products (FOB port of origin) are as follows:

• Standard manual wheelchair: $150–$300
• Ultralightweight wheelchair: $400–$800
• Power wheelchair (Group 2): $1,200–$2,500
• Rollator with seat: $60–$120
• Patient lift (manual): $800–$1,500
• Crutches (pair): $15–$30
• Cane (adjustable): $5–$15

African suppliers offer similar or slightly lower pricing (10–15% less) for manual wheelchairs but may have higher logistics costs. Lead times from LATAM average 4–8 weeks for standard products, with expedited options (2–4 weeks) available for a premium. African lead times range from 8–16 weeks due to longer shipping routes and customs processing.

US buyers should factor in import duties (0–4% under trade agreements), freight costs ($2,000–$5,000 per 20-foot container from LATAM; $4,000–$8,000 from Africa), and FDA registration fees. Total landed cost typically adds 15–25% to FOB pricing.

How Coppermont Connects Suppliers to Buyers

Coppermont bridges the gap between LATAM and African manufacturers of rehabilitation and mobility devices and US home health distributors. We provide end-to-end advisory services that streamline the export process: supplier vetting, compliance audits, logistics coordination, and buyer matching.

For suppliers, we offer market intelligence on US buyer requirements, assistance with FDA registration and 510(k) submissions, and connections to distributors, GPOs, and government buyers. For US buyers, we pre-screen manufacturers for ISO 13485 certification, FDA compliance, and production capacity, reducing due diligence time by up to 60%.

Our team has facilitated over $50 million in medical device trade between Latin America and the US, with a focus on rehabilitation and mobility products. We help negotiate contracts, manage quality assurance, and ensure timely delivery.

Supplier CTA: If you manufacture rehabilitation and mobility devices in Latin America or Africa and want to access the US market, contact Coppermont for a free market assessment.

Buyer CTA: If you are a US home health distributor seeking reliable, cost-effective suppliers of mobility devices, schedule a consultation with Coppermont to explore vetted partners.